Cite
HARVARD Citation
Gebauer, F. et al. (2020). Non-Randomised, Open Phase II Trial, Investigating Liposomal Irinotecan and 5-Fluorouraci Followed by Surgical Resection in Patients with Hepatic Oligometastatic Pancreatic Cancer (HOLIPANC). European journal of surgical oncology. 46 (2), pp. e6-. [Online].